AdaptHealth (AHCO) Income from Continuing Operations (2018 - 2026)

AdaptHealth's (AHCO) quarterly Income from Continuing Operations came in at 14873000.0 in Q1 2026, down 144.66% year-on-year from 33301276.98 in Q1 2025, and up 85.36% quarter-over-quarter from 101594000.0 in Q4 2025.

AdaptHealth (AHCO) Income from Continuing Operations (2018 - 2026) Analysis & Trends

AdaptHealth's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 14873000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 144.66% year-over-year to 14873000.0 in Q1 2026; TTM through Mar 2026 was 74889000.0, a 183.33% decrease from a year earlier, with the FY2025 full-year figure at 66054000.0, down 169.66% from the prior year.
  • Income from Continuing Operations advanced to 14873000.0 in Q1 2026 per AHCO's latest filing, from 101594000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 51411000.0 in Q4 2024 and bottomed at 452899000.0 in Q3 2023.
  • The 5-year median for Income from Continuing Operations is 15247000.0 (2022), against an average of 34579529.41.
  • Across the five-year window, Income from Continuing Operations soared 1261.12% in 2022 and slumped 15381.01% in 2023, its largest moves.
  • Year by year, Income from Continuing Operations stood at 1638000.0 in 2022, then slumped by 15381.01% to 253579000.0 in 2023, then soared by 120.27% to 51411000.0 in 2024, then sank by 297.61% to 101594000.0 in 2025, then soared by 85.36% to 14873000.0 in 2026.
  • Per Business Quant, the three latest AHCO Income from Continuing Operations figures stand at 14873000.0 (Q1 2026), 101594000.0 (Q4 2025), and 25750000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 AdaptHealth 1.42 Bn 1.38 Bn 111.50 Mn -14.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.87 Mn
Dec 31, 2025 -101.59 Mn
Sep 30, 2025 25.75 Mn
Jun 30, 2025 15.83 Mn
Mar 31, 2025 -6.08 Mn
Dec 31, 2024 51.41 Mn
Sep 30, 2024 23.96 Mn
Jun 30, 2024 20.58 Mn
Mar 31, 2024 -1.10 Mn
Dec 31, 2023 -253.58 Mn
Sep 30, 2023 -452.90 Mn
Jun 30, 2023 15.04 Mn
Mar 31, 2023 16.66 Mn
Dec 31, 2022 -1.64 Mn
Sep 30, 2022 17.21 Mn
Jun 30, 2022 15.25 Mn
Mar 31, 2022 42.23 Mn
Dec 31, 2021 23.48 Mn
Sep 30, 2021 58.27 Mn
Jun 30, 2021 80.06 Mn